NPS Pharma Reports Late-Stage Success of Bowel Condition Drug

<p>NPS Pharmaceuticals Inc.'s (NPSP) drug Gattex was successful in a late-stage study in treating patients with short bowel syndrome, reducing the amount of intravenous nutrition needed by patients with the condition